英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
274068查看　274068　在百度字典中的解释百度英翻中〔查看〕
274068查看　274068　在Google字典中的解释Google英翻中〔查看〕
274068查看　274068　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • BND-22, a first-in-class humanized ILT2-blocking antibody, promotes . . .
    In humanized mice models, blocking ILT2 with BND-22 decreased the growth of human tumors, hindered metastatic spread to the lungs, and prolonged survival of the tumor-bearing mice
  • Biond Biologics to Regain Full Rights to BND-22, a Novel Immune . . .
    About BND-22 BND-22 is a humanized IgG4 antagonist antibody targeting the ILT2 receptor, developed for the treatment of solid tumors
  • 高价买来的ILT2，现在不要了|肿瘤_新浪财经_新浪网
    值得注意的是，赛诺菲当时买下BND-22的时候，BND-22还只是一款临床前管线，刚刚向美国FDA提交IND申请。 经过4年的投入开发，BND-22现今已经推进2期
  • BND-22 – Biond Biologics
    BND-22, a novel immune checkpoint inhibitor and a first in class ILT2 (LILRB1) blocking antibody, entered Phase 1 2 trials in Q2 2021 and is being evaluated in advanced cancer patients with no alternative therapies
  • BND-22 (BND-22) - 药物靶点：LILRB1_专利_临床_研发
    BND-22 is a first-in-human ILT2 blocking antibody which has demonstrated efficient antitumor activity in various preclinical models as well as a favorable safety profile Clinical evaluation of BND-22 as a monotherapy or in combination with other therapeutics is under way in patients with cancer
  • BND-22 Biond Biologics - delta. larvol. com
    The phase 1 trial is an open-label, dose escalation and expansion study exploring the safety, tolerability, pharmacokinetics (PK), anti-tumor activity, and exploratory biomarkers for BND-22 activity in patients with select advanced solid tumors The trial is enrolling participants in medical centers in the USA and Israel "
  • Definition of anti-ILT2 monoclonal antibody BND-22 - NCI Drug . . .
    Upon administration, anti-ILT2 monoclonal antibody BND-22 targets and binds to ILT2 This prevents the binding of ILT2 ligands, including the immunosuppressive MHC molecule HLA class I histocompatibility antigen, alpha chain G (HLA-G; human leukocyte antigen G), to the ILT2 receptor and prevents ILT2-mediated signaling
  • BND 22 - AdisInsight - Springer
    BND 22 is a humanised immunoglobulin G4 (IgG4) antagonist monoclonal antibody that acts as an Ig-like transcript 2 (ILT2) inhibitor, also known as leukocyte
  • BND-22 - Drug Targets, Indications, Patents - Synapse
    BND-22 is a first-in-human ILT2 blocking antibody which has demonstrated efficient antitumor activity in various preclinical models as well as a favorable safety profile Clinical evaluation of BND-22 as a monotherapy or in combination with other therapeutics is under way in patients with cancer





中文字典-英文字典  2005-2009